Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
103.10
+3.00 (3.00%)
At close: Apr 28, 2026, 4:00 PM EDT
102.10
-1.00 (-0.97%)
After-hours: Apr 28, 2026, 4:05 PM EDT
Veradermics Market Cap
Veradermics has a market cap or net worth of $3.84 billion as of April 28, 2026.
Market Cap
3.84B
Enterprise Value
3.61B
1-Year Change
n/a
Ranking
Category
Stock Price
$103.10
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $3.84B, an increase of 189.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 3.74B | 182.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 4.16B |
| Crinetics Pharmaceuticals | 3.98B |
| Oruka Therapeutics | 3.92B |
| ACADIA Pharmaceuticals | 3.86B |
| Viking Therapeutics | 3.85B |
| Travere Therapeutics | 3.80B |
| Telix Pharmaceuticals | 3.59B |
| Tango Therapeutics | 3.57B |